½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1509816

¼¼°èÀÇ Ä£ÀÚ°¨Á¤ ¹× Ç÷¿¬°¨Á¤ ¼­ºñ½º ½ÃÀå : ¿ëµµº°, Á¦Ç°º° - Executive Consultant Guide(2024-2028³â)

Paternity & Relationship Testing Services. Global Market Forecasts by Application and by Product with Executive and Consultant Guides 2024 to 2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Howe Sound Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 154 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ Ä£ÀÚ°¨º° ¹× Ç÷¿¬°¨Á¤ ¼­ºñ½º ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ¿ëµµº°/Á¦Ç°º° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» ÀüÇص帳´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå °¡À̵å

Á¦2Àå ¼­·Ð°ú ½ÃÀåÀÇ Á¤ÀÇ

  • Ä£ÀÚ°¨Á¤ °Ë»ç¶õ ¹«¾ùÀΰ¡?
  • À¯ÀüüÇÐÀÇ Çõ¸í
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»ç ¹æ¹ý
  • ½ÃÁ¡ : ÇコÄɾî¿Í IVD ¾÷°è
  • ¿°»öü, À¯ÀüÀÚ, ¿¡ÇÇÁ¦³×ƽ½º

Á¦3Àå ½ÃÀå °³¿ä

  • ½ÃÀå Âü¿© Á¶Á÷
    • Çмú¿¬±¸±â°ü
    • Áø´Ü½ÃÇè °³¹ßÀÚ
    • °èÃø °ø±Þ¾÷ü
    • ¾àÇ° ¹× ½Ã¾à Á¦Á¶¾÷ü
    • º´¸® °ø±Þ¾÷ü
    • µ¶¸³°è ÀÓ»ó ½ÇÇè½Ç
    • °ø°ø ±¹¸³/Áö¿ª ¿¬±¸¼Ò
    • º´¿ø °Ë»ç½Ç
    • ÀÓ»ó ½ÇÇè½Ç
    • °¨»ç ±â°ü
    • ÀÎÁõ ±â°ü
  • Ç÷¿¬°¨Á¤ °Ë»ç

Á¦4Àå ½ÃÀå µ¿Çâ

  • °èÃø/ÀÚµ¿È­/Áø´Ü µ¿Çâ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦5Àå °ü°è¼º °Ë»çÀÇ ÃÖ±Ù µ¿Çâ

Á¦6Àå ÁÖ¿ä ±â¾÷ °³¿ä

  • Alphabiolabs
  • Bureau Veritas
  • Canadian DNA Services
  • Easy DNA
  • Eurofins Scientific
  • Gene by Gene, Ltd.
  • Genex Diagnostics
  • Intelligenetics
  • Invitae Corporation(Natera)
  • Laboratory Corporation of America
  • Myriad Genetics
  • Quest Diagnostics
  • Verogen

Á¦7Àå ¼¼°èÀÇ Ç÷¿¬°¨Á¤ °Ë»ç ½ÃÀå ±Ô¸ð

  • ±¹°¡º° ¼¼°è ½ÃÀå
  • ¿ëµµº° ¼¼°è ½ÃÀå
  • Á¦Ç°º° ¼¼°è ½ÃÀå

Á¦8Àå ¼¼°èÀÇ Ä£ÀÚ°¨Á¤ °Ë»ç ½ÃÀå ±Ô¸ð, ¿ëµµº°

  • ¹ý¹« ½ÃÀå
  • À̹Π°Ë»ç ½ÃÀå
  • ÀÓ»ó ½ÃÀå
  • ¼ÒºñÀÚ¿ë ½ÃÀå

Á¦9Àå ¼¼°èÀÇ Ç÷¿¬°¨Á¤ °Ë»ç ½ÃÀå ±Ô¸ð, Á¦Ç°º°

  • Àåºñ ½ÃÀå
  • ½Ã¾à ¹× Å°Æ® ½ÃÀå
  • ¼ÒÇÁÆ®¿þ¾î ½ÃÀå
  • ¼­ºñ½º ½ÃÀå
LSH 24.07.17

OVERVIEW:

Its not just paternity testing anymore! Maternity testing, Grandparent testing. Sibling testing. Infidelity testing? Who knew? It's all up for grabs in this new growth industry. Direct to Consumer genetic testing is driving the need for legally recognized relationship testing. Suppliers can benefit from non mainstream demand as well. DNA testing is crossing the chasm and moving into everyday life.

Like any service the key is reaching the customer when they are in need. Find out all about the opportunities and pitfalls in this developing industry.

This is a complex area, but this readable report will bring the entire management team up to speed, on both the technology and the opportunity. The technology is moving fast. It is coming out of the lab and onto the desktop as genetics crosses the chasm into mainstream commerce.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Relationship Testing - Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. What is Paternity & Relationship Testing?
  • 2.2. The Genomics Revolution
  • 2.3. Market Definition
    • 2.3.1. Revenue Market Size.
    • 2.3.2. Legal
    • 2.3.3. Migrant
    • 2.3.4. Clinical
    • 2.3.5. Discretionary
    • 2.3.6. Instruments
    • 2.3.7. Reagents
    • 2.3.8. Software and Services
  • 2.4. Methodology
    • 2.4.1. Methodology
    • 2.4.2. Sources
    • 2.4.3. Authors
  • 2.5. Perspective: Healthcare and the IVD Industry
    • 2.5.1. Global Healthcare Spending
    • 2.5.2. Spending on Diagnostics
    • 2.5.3. Important Role of Insurance for Diagnostics
  • 2.6. Chromosomes, Genes and Epigenetics
    • 2.6.1. Chromosomes
    • 2.6.2. Genes
    • 2.6.3. Epigenetics

3. Market Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Relationship Testing
    • 3.2.1. Overview
    • 3.2.2. Legal Use - a special case
      • 3.2.2.1. Legal
      • 3.2.2.2. Private
    • 3.2.3. Rights and Responsibilities - a complex picture
    • 3.2.4. Forensic Usage
    • 3.2.5. Clinical Uses
    • 3.2.6. Familial and Discretionary Use
    • 3.2.7. Role of Direct to Consumer Genetic Testing Services
    • 3.2.8. Immigration Use

4. Market Trends

  • 4.1. Instrumentation, Automation & Diagnostic Trends
    • 4.1.1. Traditional Automation and Centralization
    • 4.1.2. The New Automation, Decentralization and Point Of Care
    • 4.1.3. Instruments Key to Market Share
    • 4.1.4. Bioinformatics Plays a Role
    • 4.1.5. PCR Takes Command
    • 4.1.6. Next Generation Sequencing Fuels a Revolution
    • 4.1.7. NGS Impact on Pricing
    • 4.1.8. Whole Genome Sequencing, A Brave New World
    • 4.1.9. Companion Diagnostics Blurs Diagnosis and Treatment
  • 4.2. Factors Driving Growth
    • 4.2.1. Genetics Takes Center Stage
    • 4.2.2. Cultural Shifts - Changing Meaning of Family
    • 4.2.3. Media & Celebrity
    • 4.2.4. Ancestry - Changing Attitudes
  • 4.3. Factors Limiting Growth
    • 4.3.1. Increased Competition Lowers Price
    • 4.3.2. Lower Costs
    • 4.3.3. Values Shifting
    • 4.3.4. DTC Competition

5. Relationship Testing Recent Developments

  • 5.1.1. Importance of This Section
  • 5.1.2. How to Use This Section
  • 5.2. CariGenetics Launches Home Paternity Kits
  • 5.3. Genetic Technologies Global Strategy
  • 5.4. Canadian DNA lab Sells Fraudulent Tests
  • 5.5. At-Home Paternity Tests
  • 5.6. Natera Acquires Reproductive Health Assets from Invitae
  • 5.7. AlphaBiolabs launches most powerful DNA test available
  • 5.8. Fact Check: No law requires DNA testing to establish paternity in United States
  • 5.9. Maury Povich Launches At-Home Paternity Test
  • 5.10. Paternity Test Unveils IVF Mistake
  • 5.11. Anti-Trafficking Agency Conducts Paternity Tests
  • 5.12. Supreme Court limits DNA paternity testing
  • 5.13. New law proposes DNA testing to weed-out false declarations of paternity
  • 5.14. AffinityDNA Acquisition expands direct-to-consumer business
  • 5.15. EasyDNA expands markets
  • 5.16. AlphaBiolabs accredited as demand for prenatal paternity testing soars
  • 5.17. Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
  • 5.18. DNA Diagnostics Center to Join Eurofins via Acquisition
  • 5.19. Bode and Gene By Gene Receive Approval
  • 5.20. Pioneers, myDNA and FamilyTreeDNA Merge
  • 5.21. Researchers Urged to Adopt New Genomic Technologies for Relationship Testing
  • 5.22 'Not the Father': Baltimore Man Filing suit
  • 5.23. Thermo Fisher Scientific Applied Biosystems SeqStudio Genetic Analyzer for Human Identification

6. Profiles of Key Companies

  • 6.1. Alphabiolabs
  • 6.2. Bureau Veritas
  • 6.3. Canadian DNA Services
  • 6.4. Easy DNA
  • 6.5. Eurofins Scientific
  • 6.6. Gene by Gene, Ltd.
  • 6.7. Genex Diagnostics
  • 6.8. Intelligenetics
  • 6.9. Invitae Corporation (Natera)
  • 6.10. Laboratory Corporation of America
  • 6.11. Myriad Genetics
  • 6.12. Quest Diagnostics
  • 6.13. Verogen

7. Global Relationship Testing Market Size

  • 7.1. Global Market by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Country Market Shares
  • 7.2. Global Market by Application
    • 7.2.1. Table - Global Market by Application
    • 7.2.2. Chart - Application Share by Year
    • 7.2.3. Chart - Application Segment Growth Rates
    • 7.2.4. Chart - Application Segment Share Shifts
    • 7.2.5. Chart - Application Segment Share Base Year
    • 7.2.6. Chart - Application Segment Share Final Year
  • 7.3. Global Market by Product
    • 7.3.1. Table - Global Market by Product
    • 7.3.2. Chart - Product Share by Year
    • 7.3.3. Chart - Product Segment Growth Rates
    • 7.3.4. Chart - Product Segment Share Shifts
    • 7.3.5. Chart - Product Segment Share Base Year
    • 7.3.6. Chart - Product Segment Share Final Year

8. Global Relationship Market Sizes by Application

  • 8.1. Legal Market
    • 8.1.1. Table Legal - by Country
    • 8.1.2. Chart - Legal Growth
  • 8.2. Migrant Testing Market
    • 8.2.1. Table Migrant - by Country
    • 8.2.2. Chart - Migrant Growth
  • 8.3. Clinical Market
    • 8.3.1. Table Clinical - by Country
    • 8.3.2. Chart - Clinical Growth
  • 8.4. Consumer Discretionary Market
    • 8.4.1. Table Consumer Discretionary - by Country
    • 8.4.2. Chart - Consumer Discretionary Growth

9. Global Relationship Testing Market by Product

  • 9.1. Instruments Market
    • 9.1.1. Table Instruments - by Country
    • 9.1.2. Chart - Instrument Growth
  • 9.2. Reagents and Kits Market
    • 9.2.1. Table Reagents and Kits - by Country
    • 9.2.2. Chart - Reagents and Kits Growth
  • 9.3. Software Market
    • 9.3.1. Table Software - by Country
    • 9.3.2. Software Growth
  • 9.4. Services Market
    • 9.4.1. Table Services - by Country
    • 9.4.2. Chart - Services Growth

Tables

  • Table 1: The Base Pairs
  • Table 2: Market Players by Type
  • Table 3: The Different Types of Relationship Tests
  • Table 4: Seven Key Diagnostic Laboratory Technology Trends
  • Table 5: Factors Driving Growth
  • Table 6: Four Factors Limiting Growth
  • Table 7: Global Market by Country
  • Table 8: Global Market by Application
  • Table 9: Global Market by Product
  • Table 10: Legal Segment by Country
  • Table 11: Migrant Segment by Country
  • Table 12: Clinical Segment by Country
  • Table 13: Consumer Discretionary Segment by Country
  • Table 14: Instruments Segment by Country
  • Table 15: Reagents and Kits Segment by Country
  • Table 16: Software Segment by Country
  • Table 17: Services Segment by Country

Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: DNA Strands and Chromosomes
  • Figure 4: Karyogram of Human Chromosomes
  • Figure 5: Size of Various Genomes
  • Figure 6: The Road to Diagnostics
  • Figure 7: Centralized vs. Decentralized Laboratory Service
  • Figure 8: A Highly Multiplexed Syndromic Testing Unit
  • Figure 9: The Real Cost to Sequence the Human Genome
  • Figure 10: The Codevelopment Process
  • Figure 11: Country Market Shares
  • Figure 12: Application Share by Year
  • Figure 13: Application Segment Growth Rates
  • Figure 14: Segment Share Shifts
  • Figure 15: Application Segment Share Base Year
  • Figure 16: Application Segment Share Final Year
  • Figure 17: Product Share by Year
  • Figure 18: Product Segment Growth Rates
  • Figure 19: Product Segment Share Shifts
  • Figure 20: Product Segment Share Base Year
  • Figure 21: Product Segment Share Final Year
  • Figure 22: Legal vs. Total Market Growth
  • Figure 23: Migrant vs. Total Market Growth
  • Figure 24: Clinical vs. Total Market Growth
  • Figure 25: Consumer Discretionary vs. Total Market Growth
  • Figure 26: Instrument vs. Total Market Growth
  • Figure 27: Reagents and Kits vs. Total Market Growth
  • Figure 28: Software vs. Total Market Growth
  • Figure 29: Services vs. Total Market Growth
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦